DOCSLIB.ORG

US EPA, Pesticide Product Label, Avalaire S-Metolachlor + Metribuzin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
US EPA, Pesticide Product Label, Avalaire S-Metolachlor + Metribuzin U.S. ENVIRONMENTAL PROTECTION AGENCY EPA Reg. Number: Date of Issuance: Office of Pesticide Programs Registration Division (7505P) 93930-54 4/28/21 1200 Pennsylvania Ave., N.W. Washington, D.C. 20460 NOTICE OF PESTICIDE: Term of Issuance: X Registration Reregistration Conditional (under FIFRA, as amended) Name of Pesticide Product: Avalaire S-Metolachlor + Metribuzin + Imazethapyr Name and Address of Registrant (include ZIP Code): Beth Anderson Senior Regulatory Manager Avalaire, LLC 1204 Village Market Place, #173 Morrisville, NC 27560 Note: Changes in labeling differing in substance from that accepted in connection with this registration must be submitted to and accepted by the Registration Division prior to use of the label in commerce. In any correspondence on this product always refer to the above EPA registration number. On the basis of information furnished by the registrant, the above named pesticide is hereby registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Registration is in no way to be construed as an endorsement or recommendation of this product by the Agency. In order to protect health and the environment, the Administrator, on his motion, may at any time suspend or cancel the registration of a pesticide in accordance with the Act. The acceptance of any name in connection with the registration of a product under this Act is not to be construed as giving the registrant a right to exclusive use of the name or to its use if it has been covered by others. This product is conditionally registered in accordance with FIFRA section 3(c)(7)(A). You must comply with the following conditions: 1. Submit and/or cite all data required for registration/reregistration/registration review of your product under FIFRA when the Agency requires all registrants of similar products to submit such data. Continued on page 2 Signature of Approving Official: Date: 4/28/21 Mindy Ondish, Product Manager 23 Herbicide Branch, Registration Division (7505P) EPA Form 8570-6 Registration Notice Conditional v.20150320 Page 2 of 2 EPA Reg. No. 93930-54 Decision No. 568684 2. You are required to comply with the data requirements described in the generic data call-ins (GDCIs) identified below: a. Metribuzin GDCI-101101-1304 and GDCI-101101-1825 You must comply with all of the data requirements within the established deadlines. If you have questions about the GDCIs listed above, you may contact the Chemical Review Manager in the Pesticide Reevaluation Division: http://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:1 3. Submit one copy of the final printed label for the record before you release the product for shipment. Should you wish to add/retain a reference to the company’s website on your label, then please be aware that the website becomes labeling under FIFRA and is subject to review by the Agency. If the website is false or misleading, the product would be misbranded and unlawful to sell or distribute under FIFRA section 12(a)(1)(E). 40 CFR 156.10(a)(5) list examples of statements EPA may consider false or misleading. In addition, regardless of whether a website is referenced on your product’s label, claims made on the website may not substantially differ from those claims approved through the registration process. Therefore, should the Agency find or if it is brought to our attention that a website contains false or misleading statements or claims substantially differing from the EPA approved registration, the website will be referred to the EPA’s Office of Enforcement and Compliance. If you fail to satisfy these data requirements, EPA will consider appropriate regulatory action including, among other things, cancellation under FIFRA section 6(e). Your release for shipment of the product constitutes acceptance of these conditions. A stamped copy of the label is enclosed for your records. Please note that the alternate brand name, “Stridero” has been added to the product record. Please also note that the record for this product currently contains the following CSF: Basic CSF dated 12/04/2020 If you have any questions, you may contact Jamie Harrington by email at [email protected]. Enclosure 04/28/2021 [Note to reviewer: [Text] in brackets denotes optional or explanatory language [Note to reviewer: {Text} in braces denotes where in the final label text will appear 93930-54 {BOOKLET FRONT PANEL LANGUAGE} S-METOLACHLOR GROUP 15 HERBICIDE METRIBUZIN GROUP 5 HERBICIDE IMAZETHAPYR GROUP 2 HERBICIDE AVALAIRE S-METOLACHLOR + METRIBUZIN + IMAZETHAPYR[™] [Alternate Brand Name: Stridero] [Herbicide for pre-emergent control of certain grasses and broadleaf weeds in soybeans.] ACTIVE INGREDIENTS: (% by weight) S-Metolachlor*………………………………………….……………………………………………………………………………..…………………… 37.08% Metribuzin**………………………………………….……………………………………………………………………………..………………………. 8.23% Imazethapyr***……………………………………….……………………………………………………………………………..……………………... 1.83% OTHER INGREDIENTS: ……………………………………………………..………………………………………………………….……………….. 52.86% TOTAL …………………………………………………………………………………………………………….……………………………………………. 100.0% *contains 3.38 Ib of S-metolachlor per gallon. **contains 0.75 Ib of metribuzin per gallon. ***contains 0.17 Ib of imazethapyr acid per gallon. KEEP OUT OF REACH OF CHILDREN CAUTION Si usted no entiende la etiqueta, busque a alguien para que se la explique a usted en detalle. (If you do not understand the label, find someone to explain it to you in detail.) See [below] [inside label booklet] for [additional] [First Aid,] [Precautionary Statements] and [Directions for Use]. FIRST AID If on skin or • Take off contaminated clothing. clothing: • Rinse skin immediately with plenty of water for 15-20 minutes. • Call a poison control center or doctor for treatment advice. If swallowed: • Call a poison control center or doctor immediately for treatment advice. • Have person sip a glass of water if able to swallow. • Do not induce vomiting unless told to do so by the poison control center or doctor. • Do not give anything by mouth to an unconscious person. If in eyes: • Hold eye open and rinse slowly and gently with water for 15-20 minutes. • Remove contact lenses, if present, after the first 5 minutes, then continue rinsing eye. • Call a poison control center or doctor for treatment advice. If inhaled: • Move person to fresh air. • If person is not breathing, call 911 or an ambulance, then give artificial respiration, preferably mouth-to-mouth, if possible. • Call a poison control center or doctor for further treatment advice. HOT LINE NUMBER 1 Have the product container or label with you when calling a poison control center or doctor, or going for treatment. You may also contact SafetyCall at 1-844-685-9173 for emergency medical treatment information. For Chemical Emergency: Spill, Leak, Fire, Exposure, or Accident, Call CHEMTREC Day or Night Within USA and Canada: 1-800-424-9300 or +1 703-527-3887 (collect calls accepted) EPA Reg. No.: 93930-54 EPA Est. No.: Net Weight: Manufactured for: Avalaire, LLC 1204 Village Market Place, #173 Morrisville, NC 27560 2 {LANGUAGE INSIDE BOOKLET} PRECAUTIONARY STATEMENTS HAZARDS TO HUMANS AND DOMESTIC ANIMALS CAUTION Harmful if absorbed through skin. Harmful if swallowed. Causes moderate eye irritation. Avoid contact with skin, eyes or clothing. Prolonged or frequently repeated skin contact may cause allergic reactions in some people. Wash thoroughly with soap and water after handling and before eating, drinking, chewing gum, using tobacco or using the toilet. Remove and wash contaminated clothing before reuse. Personal Protective Equipment (PPE) Mixers, loaders, applicators, flaggers and other handlers must wear: • Protective eyewear, • Coveralls worn over short-sleeved shirt and short pants, • Chemical-resistant gloves made out of butyl rubber > 14 mils or barrier laminate, • Chemical-resistant footwear plus socks, and • Chemical-resistant apron when cleaning equipment, spills, mixing and loading and when otherwise exposed to this product’s concentrate. Follow manufacturer’s instructions for cleaning/maintaining PPE. If no such instructions for washables exist, use detergent and hot water. Keep and wash PPE separately from other laundry. Engineering Controls When handlers use closed systems, enclosed cabs, or aircraft in a manner that meets the requirements listed in the Worker Protection Standard (WPS) for agricultural pesticides, the handler PPE requirements may be reduced or modified as specified in the WPS (40 CFR 170.607(d-f)). USER SAFETY RECOMMENDATIONS Users should: Wash thoroughly with soap and water after handling and before eating, drinking, chewing gum, using tobacco or using the toilet. • Remove clothing/PPE immediately if pesticide gets inside. Then wash thoroughly and put on clean clothing. • Remove and wash contaminated clothing before reuse. • Remove PPE immediately after handling this product. Wash the outside of gloves before removing. As soon as possible, wash thoroughly and change into clean clothing. ENVIRONMENTAL HAZARDS Do not apply directly to water, or to areas where surface water is present or to intertidal areas below the mean high water mark. Do not contaminate water when disposing of equipment washwaters or rinsate. Surface Water Advisory S-Metolachlor may impact surface water quality due to runoff of rain water. This is especially true for poorly draining soils and soils with shallow ground water. This product is classified as having high potential for reaching surface water via runoff for several weeks or months after application. A level, well-maintained
Load more

Recommended publications
  • US EPA, Pesticide Product Label, A335.06,09/21/2020
    [Note to reviewer: [Text] in brackets denotes optional or explanatory language [Note to reviewer: {Text} in braces denotes where in the final label text will appear {BOOKLET FRONT PANEL LANGUAGE} S-METOLACHLOR GROUP 15 HERBICIDE METRIBUZIN GROUP 5 HERBICIDE FOMESAFEN GROUP 14 HERBICIDE A335.06[™] [Alternate Brand Name: Statler] [Herbicide for preemergent control of certain grasses and broadleaf weeds in Soybeans] ACTIVE INGREDIENTS: (% by weight) S-Metolachlor*………………………………………….……………………………………………………………………………..…………………… 36.29% Metribuzin**………………………………………….……………………………………………………………………………..………………………. 8.05% Fomesafen***………………………………………….……………………………………………………………………………..……………………... 7.16% OTHER INGREDIENTS: ……………………………………………………..…………………………………………………………………………….. 48.5% TOTAL …………………………………………………………………………………………………………….……………………………………………. 100.0% *contains 3.39 Ib of S-metolachlor per gallon **contains 0.75 Ib of metribuzin per gallon ***contains 0.67 Ib of fomesafen acid per gallon KEEP OUT OF REACH OF CHILDREN CAUTION Si usted no entiende la etiqueta, busque a alguien para que se la explique a usted en detalle. (If you do not understand the label, find someone to explain it to you in detail.) See [below] [inside label booklet] for [additional] [First Aid,] [Precautionary Statements] and [Directions for Use]. EPA Reg. No.: 91234-201 EPA Est. No.: Net Weight: Manufactured for: Atticus, LLC 5000 CentreGreen Way, Suite 100 Cary, NC 27513 1 {LANGUAGE INSIDE BOOKLET} FIRST AID If on skin or Take off contaminated clothing. clothing: Rinse skin immediately with plenty of water for 15-20 minutes. Call a poison control center or doctor for treatment advice. If swallowed: Call a poison control center or doctor immediately for treatment advice. Have person sip a glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison control center or doctor.
    [Show full text]
  • Acetylcholinesterase — New Roles for Gate a Relatively Long Distance to Reach the Active Site, Ache Is One of the Fastest an Old Actor Enzymes14
    PERSPECTIVES be answered regarding AChE catalysis; for OPINION example, the mechanism behind the extremely fast turnover rate of the enzyme. Despite the fact that the substrate has to navi- Acetylcholinesterase — new roles for gate a relatively long distance to reach the active site, AChE is one of the fastest an old actor enzymes14. One theory to explain this phe- nomenon has to do with the unusually strong electric field of AChE. It has been argued that Hermona Soreq and Shlomo Seidman this field assists catalysis by attracting the cationic substrate and expelling the anionic The discovery of the first neurotransmitter — understanding of AChE functions beyond the acetate product15. Site-directed mutagenesis, acetylcholine — was soon followed by the classical view and suggest the molecular basis however, has indicated that reducing the elec- discovery of its hydrolysing enzyme, for its functional heterogeneity. tric field has no effect on catalysis16.However, acetylcholinesterase. The role of the same approach has indicated an effect on acetylcholinesterase in terminating From early to recent discoveries the rate of association of fasciculin, a peptide acetylcholine-mediated neurotransmission The unique biochemical properties and phys- that can inhibit AChE17. made it the focus of intense research for iological significance of AChE make it an much of the past century. But the complexity interesting target for detailed structure–func- of acetylcholinesterase gene regulation and tion analysis. AChE-coding sequences have recent evidence for some of the long- been cloned so far from a range of evolution- a Peripheral Choline binding site suspected ‘non-classical’ actions of this arily diverse vertebrate and invertebrate binding enzyme have more recently driven a species that include insects, nematodes, fish, site profound revolution in acetylcholinesterase reptiles, birds and several mammals, among Active site research.
    [Show full text]
  • Green Mamba Peptide Targets Type-2 Vasopressin Receptor Against Polycystic Kidney Disease
    Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease Justyna Cioleka,1, Helen Reinfrankb,1,2, Lo¨ıc Quintonc, Say Viengchareund, Enrico A. Sturaa, Laura Veraa,3, Sabrina Sigismeaua, Bernard Mouillace,Hel´ ene` Orcele, Steve Peigneurf, Jan Tytgatf, Laura Droctove´ a, Fabrice Beaua, Jerome Nevouxd, Marc Lombes` d, Gilles Mouriera, Edwin De Pauwc, Denis Serventa, Christiane Mendree,4, Ralph Witzgallb,4, and Nicolas Gillesa,4 aService d’Ingenierie´ Moleculaire´ des Proteines,´ Institut des Sciences du Vivant Fred´ eric´ Joliot, Commissariat a` l’Energie Atomique, Universite´ Paris-Saclay, F-91191 Gif sur Yvette, France; bInstitute for Molecular and Cellular Anatomy, University of Regensburg, 93053 Regensburg, Germany; cLaboratoire de Spectrometrie´ de Masse, Unite´ de Recherche Molecular Systems, Universite´ de Liege,` Liege` 4000, Belgium; dINSERM U1185, Universite´ Paris Sud, Universite´ Paris-Saclay, F-94276, Le Kremlin-Bicetre,ˆ France; eInstitut de Genomique´ Fonctionnelle, CNRS, INSERM, Universite´ Montpellier, F-34094 Montpellier, France; and fLaboratory of Toxicology, University of Leuven, Leuven B-3000, Belgium Edited by David W. Russell, University of Texas Southwestern Medical Center, Dallas, TX, and approved April 13, 2017 (received for review December 17, 2016) Polycystic kidney diseases (PKDs) are genetic disorders that can therapeutic approach, the use of V2R antagonists has certain cause renal failure and death in children and adults. Lowering advantages (7, 8). Most renal ADPKD cysts develop within the cAMP in cystic tissues through the inhibition of the type-2 vaso- vasopressin-sensitive tubular parts of the nephron, where vaso- pressin receptor (V2R) constitutes a validated strategy to reduce pressin is also the main hormonal regulator of adenylyl cyclase disease progression.
    [Show full text]
  • Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com
    Hallucinogens And Dissociative Drug Use And Addiction Introduction Hallucinogens are a diverse group of drugs that cause alterations in perception, thought, or mood. This heterogeneous group has compounds with different chemical structures, different mechanisms of action, and different adverse effects. Despite their description, most hallucinogens do not consistently cause hallucinations. The drugs are more likely to cause changes in mood or in thought than actual hallucinations. Hallucinogenic substances that form naturally have been used worldwide for millennia to induce altered states for religious or spiritual purposes. While these practices still exist, the more common use of hallucinogens today involves the recreational use of synthetic hallucinogens. Hallucinogen And Dissociative Drug Toxicity Hallucinogens comprise a collection of compounds that are used to induce hallucinations or alterations of consciousness. Hallucinogens are drugs that cause alteration of visual, auditory, or tactile perceptions; they are also referred to as a class of drugs that cause alteration of thought and emotion. Hallucinogens disrupt a person’s ability to think and communicate effectively. Hallucinations are defined as false sensations that have no basis in reality: The sensory experience is not actually there. The term “hallucinogen” is slightly misleading because hallucinogens do not consistently cause hallucinations. 1 ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com How hallucinogens cause alterations in a person’s sensory experience is not entirely understood. Hallucinogens work, at least in part, by disrupting communication between neurotransmitter systems throughout the body including those that regulate sleep, hunger, sexual behavior and muscle control. Patients under the influence of hallucinogens may show a wide range of unusual and often sudden, volatile behaviors with the potential to rapidly fluctuate from a relaxed, euphoric state to one of extreme agitation and aggression.
    [Show full text]
  • Snap-On Industrial April 23, 1014 Page 1 Item Number Description
    Snap-on Industrial April 23, 1014 Unit of Item Number Description Net Price Measure 00000072E00 TURNTABLE VTA 1 SET 2 PC 550.27 Each 00000096000 DEPRESSOR ASSY-PEDAL 35.37 Each 00000129000 ALIGNMENT WHEEL STANDS 1309.19 Each 00001260000 TURNTABLE TRUCK 1 SET OF 2 1210.66 Each 00006310000 CONE-ADAPT. SET CAN USE 110612 300.54 Each 00043102Q00 ECONO 4-POST 172 7904.23 Each 00044218Q00 4 POST CLOSED CENTER 18K LIFT 22045.54 Each 00055502000 CLAMP ASSY-WHEEL,STEER 62.31 Each 00058839000 TOOL-PDQ WEIGHT PASS CAR 34.5 Each 00060466000 DUAL WHEEL SPACER 160.5 Each 00060779000 CONE-MEDIUM 9 1/2 DEG 82.1 Each 00060873000 CONE-TRUCK GRIND 241.29 Each 00060874000 SPACER-WHEEL TRUCK 173.82 Each 00064222000 REAR SLIPPLATES 483.82 Each 00066006000 LUBE BOTTLE 24.18 Each 00090488000 TRI TIPS/SETS SCREWS- 10 44.06 Each 00110560000 CONE-CENTERING 75-110MM HAWE 79.55 Each 00110612000 TRUCK CONE KIT 261.4 Each 00110614000 ADAPTER-UNILUG SEE REMARKS 538.16 Each 00112094000 OPTIONAL HVY DTY KIT 3.5 1456.61 Each 00112109000 DAYTON WHEEL ADAPTER 24 1033 Each 00112111000 4 ARM STAR QK ADPTR 702958178 889.5 Each 00112112000 5 ARM STAR QK ADPTR 702958179 942 Each 00112113000 4 TO 5 STAR UPDATE KT70295818 412.5 Each 00112292000 220.1MM HWKA 70BE958-008 321.54 Each 00112320000 DISC-220.8MM 70BE 958 007 448.33 Each 10002MRMHCDI TORQUE WRENCH 150-1000INLB 110.36 Each 10-01085A LOCK-N-ROLL LATCH 67 IN. 3.09 Each 10-01185A LOCK N ROLL LATCH FOR KRL1099 1.83 Each 1001XL36PV SLDG TRAY 21.45 Each 10-03783A TR DR SLVR EPLS 27.99 KRSC30 2.02 Each 10059 BEARING NEEDLE THRUST
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • M4 Muscarinic Receptors Are Involved in Modulation of Neurotransmission at Synapses of Schaffer Collaterals on CA1 Hippocampal Neurons in Rats
    Journal of Neuroscience Research 87:691–700 (2009) M4 Muscarinic Receptors Are Involved in Modulation of Neurotransmission at Synapses of Schaffer Collaterals on CA1 Hippocampal Neurons in Rats Gonzalo Sa´nchez,1 Lucas de Oliveira Alvares,2,3 Marı´a Victoria Oberholzer,1 Bruna Genro,2 Jorge Quillfeldt,2 Jaderson Costa da Costa,3 Carlos Cerven˜ansky,4 Diana Jerusalinsky,1 and Edgar Kornisiuk1* 1Laboratorio de Neuroplasticidad y Neurotoxinas, Instituto de Biologı´a Celular y Neurociencias, Facultad de Medicina, Universidad de Buenos Aires y CONICET, Buenos Aires, Argentina 2Laborato´rio de Psicobiologia e Neurocomputac¸a˜o, Dep. de Biofisica, Instituto de Biocieˆncias, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 3Laborato´rio de Neurocieˆncias, Instituto de Pesquisas Biome´dicas, Pontificia Universidade Cato´lica do Rio Grande do Sul, Porto Alegre, Brazil 4Instituto Pasteur de Montevideo e IIBCE, Montevideo, Uruguay All five subtypes of muscarinic acetylcholine receptors Key words: muscarinic acetylcholine receptor; CA1 (mAChR; M1–M5) are expressed in the hippocampus, synapses; long-term potentiation; rat hippocampus; where they are involved both in cognitive functions and muscarinic toxin 3 in synaptic plasticity, such as long-term potentiation (LTP). Muscarinic toxins (MTs) are small proteins from All five subtypes of muscarinic acetylcholine recep- mamba snake venoms that display exquisite discrimi- tors (mAChR; M1–M5; Bonner et al., 1987) are nation between mAChRs. MT1 acts as an agonist at expressed in the hippocampus
    [Show full text]
  • Antivenin Plants Used for Treatment of Snakebites in Uganda
    Omara et al. Tropical Medicine and Health (2020) 48:6 Tropical Medicine https://doi.org/10.1186/s41182-019-0187-0 and Health REVIEW Open Access Antivenin plants used for treatment of snakebites in Uganda: ethnobotanical reports and pharmacological evidences Timothy Omara1,2* , Sarah Kagoya3,4, Abraham Openy5, Tom Omute6, Stephen Ssebulime7, Kibet Mohamed Kiplagat8 and Ocident Bongomin9 Abstract Snakebite envenomation is a serious public health concern in rural areas of Uganda. Snakebites are poorly documented in Uganda because most occur in rural settings where traditional therapists end up being the first-line defense for treatment. Ethnobotanical surveys in Uganda have reported that some plants are used to antagonize the activity of various snake venoms. This review was sought to identify antivenin plants in Uganda and some pharmacological evidence supporting their use. A literature survey done in multidisciplinary databases revealed that 77 plant species belonging to 65 genera and 42 families are used for the treatment of snakebites in Uganda. The majority of these species belong to family Fabaceae (31%), Euphorbiaceae (14%), Asteraceae (12%), Amaryllidaceae (10%) and Solanaceae (10%). The main growth habit of the species is shrubs (41%), trees (33%) and herbs (18%). Antivenin extracts are usually prepared from roots (54%) and leaves (23%) through decoctions, infusions, powders, and juices, and are administered orally (67%) or applied topically (17%). The most frequently encountered species were Allium cepa, Carica papaya, Securidaca longipedunculata, Harrisonia abyssinica, and Nicotiana tabacum. Species with global reports of tested antivenom activity included Allium cepa, Allium sativum, Basella alba, Capparis tomentosa, Carica papaya, Cassia occidentalis, Jatropa carcus, Vernonia cinereal, Bidens pilosa, Hoslundia opposita, Maytensus senegalensis, Securinega virosa, and Solanum incanum.
    [Show full text]
  • Herbicide 900 Ml &
    SEE ENCLOSED PAMPHLET FOR FULL SIEN INGESLOTE PAMFLET VIR VOLLEDIGE PARTICULARS BESONDERHEDE Reg. No. L8525 (Act No. 36 of 1947) Reg. Nr. L8525 (Wet Nr. 36 van 1947) Namibian Reg No. N-AR 1572 Namibiese Reg. Nr. N-AR 1572 A suspension concentrate post- 'n Suspensie konsentraat na emergence herbicide for the control opkoms onkruiddoder vir die Herbicide of certain broadleaf and grass weeds beheer van sekere breëblaar- en A suspension concentrate post- in maize and sugarcane. grasonkruide in mielies en emergence herbicide for the suikerriet. control of certain broadleaf and grass weeds in maize and sugarcane. HERBICIDE GROUP CODE F2 ONKRUIDDODERGROEPKODE contains: Tembotrione (Triketone) and Isoxadifen-ethyl (Safener) Active ingredients: Aktiewe bestanddele: Tembotrione (Triketone)..........................420 g/l Tembotrione (Triketone).........................420 g/l Isoxadifen-ethyl (Safener).......................210 g/l Isoxadifen-etiel (Beveiliger)....................210 g/l REGISTERED BY / GEREGISTREER DEUR: Bayer (Pty) Ltd / (Edms) Bpk Reg. 1968/011192/07 P.O. Box/Posbus 143 Isando 1600 South Africa/Suid-Afrika TEL: (OFFICE HOURS) / (KANTOORURE) (011) 921 5911 IN CASE OF POISONING PLEASE PHONE / IN GEVAL VAN VERGIFTIGING SKAKEL: 0861555777 Laudis® is a registered trademark of the Bayer Group. Laudis® is ‘n geregistreerde handelsmerk van die Bayer Groep. © Bayer (Pty) Ltd Packaging / Verpakking: BATCH NUMBER: 900 ml & 5 L LOTNOMMER: See on pack DATE OF MANUFACTURE: Sien op houer HARMFUL DATUM VERVAARDIG: SKADELIK RSA/0318/Laudis 900ml/Sales Panel Code: 84951498D Herbicide WARNINGS: DO NOT GRAZE OR USE PLANTS AS FODDER FROM TREATED MAIZE WITHIN 70 DAYS OF LAST APPLICATION. DO NOT USE PLANTS AS FODDER FROM TREATED SUGARCANE WITHIN 235 DAYS OF LAST APPLICATION.
    [Show full text]
  • EMERGING DRUG TRENDS – 2014 Special Research Report • Regional Organized Crime Information Center
    EMERGING DRUG TRENDS – 2014 Special Research Report • Regional Organized Crime Information Center Emerging Drug Trends Table of Contents Opioid Abuse .................................................... 2 By ROCIC Publications Specialist Jennifer Adkins Opiate Abuse .................................................... 7 © Regional Organized Crime Information Center Synthetic Cathinones ..................................... 13 ew drugs are emerging at an unprecedented rate as manufacturers Synthetic Cannabinoids ................................. 18 of “legal high” products use new chemicals to replace those that Phenethlyamines ............................................ 22 N Party Pills ...................................................27 are banned. These new chemicals take the place of heroin, morphine, and amphetamines. These drugs are highly accessible, touted as legal, Herbal Drugs ..............................................29 Sources of Information ...............................32 and perceived as safe. This Special Research Report was supported by Grant No. 2011-RS-CX-K007, awarded by the Bureau of Justice Assistance, Office of Justice Programs, U.S. However, despite the popularity in designer drugs and legal high Department of Justice. The Office of Justice Programs also coordinates the activi- ties of the Bureau of Justice Statistics, the National Institute of Justice, the Office of products, the abuse of heroin and prescription painkiller medication Juvenile Justice and Delinquency, and the Office for Victims of Crime.
    [Show full text]
  • New Addictive Drugs
    Hemmat Ali Mohammed 9th April 2020, Done on 2nd April at 8:30 AM (Voodoo & Strox Assignment) New addictive drugs Synthetic cannabinoids (SC) are a new class of psychoactive substances, it is potent agonists of cannabinoid receptors, which mimic the psychoactive effects of the principal psychoactive component of cannabis. It is a drug with properties and effects similar to a known hallucinogen or narcotic but having a slightly altered chemical structure. SC are the widest and most diffused class of Novel Psychoactive Substances. History: 2005: Synthetic cannabinoids first emerged in Europe. 2009: Appeared in the United States, where it was marketed initially as “K2” and “Spice” and inhaled via a pipe or rolled into a cigarette. 2014: Two new drugs known as Strox and Voodoo have hit the Egyptian market. Street and commercial names for SC products: K2, Spice, Barely Legal, Black Mamba, Galaxy, Mojo, and Yucatan Fire. Voodoo: Voodoo is a mixture of herbs and spices that are sprayed with a synthetic compound that mimics the effects of (Tetrahydrocannabinol) THC. Voodoo spice is marketed as an herbal incense. It is a synthetic cannabinoid that is up to 100 times as powerful as natural marijuana. The most common brand is "Mister Nice Guy", which is sold in a small bag decorated with a smiley emoticon. The bag has a warning that reads “relaxing incense, not edible”. 1 Strox: Strox is popular synthetic cannabis in Egypt that consists of smokable herbal products laced with synthetic cannabinoids (THC) analogues. Strox is the Egyptian version of the Spice in which Atropa Belladonna, Datura or Hyposymus is used as plant matrix to be enhanced with unidentified synthetic cannabinoids.
    [Show full text]
  • Health Alert Movement 2019: Detroit Electronic Music Festival Hart Plaza Downtown Detroit May 25-28, 2019
    Health Alert Movement 2019: Detroit Electronic Music Festival Hart Plaza Downtown Detroit May 25-28, 2019 In this issue Updates for 2019 .............................................................................................................. 2 Prehospital Concerns ....................................................................................................... 3 Hospital Concerns ............................................................................................................ 4 THC .................................................................................................................................. 5 THC Homologs ................................................................................................................. 5 Stimulants......................................................................................................................... 7 Opioids ........................................................................................................................... 10 GABA-B .......................................................................................................................... 12 NMDA ............................................................................................................................. 13 Inhalants ......................................................................................................................... 14 Other Hallucinogens ......................................................................................................
    [Show full text]